Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 2
Results: 15
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 329, doi. 10.1007/s00262-017-2101-0
- By:
- Publication type:
- Article
Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 271, doi. 10.1007/s00262-017-2086-8
- By:
- Publication type:
- Article
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 285, doi. 10.1007/s00262-017-2085-9
- By:
- Publication type:
- Article
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 261, doi. 10.1007/s00262-017-2083-y
- By:
- Publication type:
- Article
Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 161, doi. 10.1007/s00262-017-2082-z
- By:
- Publication type:
- Article
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 247, doi. 10.1007/s00262-017-2081-0
- By:
- Publication type:
- Article
Clinicopathologic implications of CD8<sup>+</sup>/Foxp3<sup>+</sup> ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 209, doi. 10.1007/s00262-017-2080-1
- By:
- Publication type:
- Article
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 299, doi. 10.1007/s00262-017-2079-7
- By:
- Publication type:
- Article
Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 195, doi. 10.1007/s00262-017-2077-9
- By:
- Publication type:
- Article
A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 183, doi. 10.1007/s00262-017-2076-x
- By:
- Publication type:
- Article
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 311, doi. 10.1007/s00262-017-2073-0
- By:
- Publication type:
- Article
Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 225, doi. 10.1007/s00262-017-2070-3
- By:
- Publication type:
- Article
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 175, doi. 10.1007/s00262-017-2069-9
- By:
- Publication type:
- Article
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 237, doi. 10.1007/s00262-017-2066-z
- By:
- Publication type:
- Article